Share this page

  • Haleon’s Re/Wire Health Studio selects six emerging consumer health and tech companies around the world to join its third cohort  
  • Programme aimed at discovering and scaling early-stage consumer health innovators
  • Cohort three includes start-ups with cutting-edge solutions in everyday oral health, behavioural health, women’s health and emerging microbiome science

01 December 2022: Consumer health start-ups focused on oral health and behaviour change are amongst those chosen for the third cohort of the Re/Wire Health Studio, a game-changing global collaboration and partnership programme from Haleon NEXT, the disruptive innovation arm of global consumer health company Haleon.

After a highly competitive application process, the six start-ups were selected for their potential to help shape the future of consumer health. Haleon’s Re/Wire programme partners with founders who share the company’s ambition to deliver better everyday health to consumers by developing the next generation of digital health services which will enable people to better manage their overall health and wellbeing.

The six successful start-ups are:

–   Truthbrush: A detachable device that uses a motion sensor to track and analyse the oral health of families. It can suggest improvements to brushing techniques.

–   Leucine Rich Bio: A genomics-based company providing an at-home gut microbiome test that detects susceptibility of 16 diseases, and provides prebiotic, probiotic and nutritional recommendations.

–   Oral Genome: A dental saliva test card that helps patients and dentists analyse oral health and identify personalised recommendations that can address root causes of issues and therefore prevent chronic diseases developing.

–   Kwit: KWIT builds mobile applications that assist people with behaviour change through application of CBT. Their first app focuses on smoking cessation. The company is developing a platform capability to allow its CBT approach to extend into new areas of mental wellness.

–   Minti: An oral care brand offering a complete eco-system of technology and digital services to address all oral health care needs.

–   Lisa Health: A digital health solution for menopause and healthy ageing that leverages artificial intelligence to track symptoms like hot flashes and sleep disturbance and generate personalised insights and support.

Founders at the six companies will benefit from a three-month virtual support programme, with a carefully curated development programme covering strategy road-mapping, product viability, brand development, behavioural economics and regulatory compliance. They will also benefit from Haleon’s insights into fast-track global scaling and commercialisation, as well as networking opportunities. In addition, R/GA Ventures - will be on hand to help cohort participants prepare for future milestones.

The success of the Re/Wire Health Studio continues apace, with the third cohort of digital health tech innovators selected within 12 months of the programme’s launch. This latest phase – which sees the programme expand to include companies from across EMEA, US and India – has uncovered potentially transformational consumer health innovations and innovators in the fields of oral care, behaviour change, women’s health and gut microbiome. We’re forging partnerships with several of the emerging companies from the previous two cohort alumni and look forward to seeing where this new Re/Wire cohort takes us.

Nick Tate

VP and Head of Haleon NEXT


Media Contacts

Laura Webster / [email protected] / +447780494905

About Haleon NEXT

Haleon NEXT is the strategic commercial growth engine for Haleon, focused on the creation and scaling of net-new product, service and platform businesses across everyday health.

About Haleon

Haleon (LSE: HLN) is a global leader in consumer health, with brands trusted by millions of consumers globally. The group employs over 22,000 people across 170 markets, who are united by Haleon’s purpose - to deliver better everyday health with humanity. Haleon’s product portfolio spans five major categories - Oral Health, Pain Relief, Respiratory Health, Digestive Health and Other, and Vitamins, Minerals and Supplements (VMS). Its long-

standing brands - such as Advil, Sensodyne, Panadol, Voltaren, Theraflu, Otrivin, Polident, parodontax and Centrum - are built on trusted science, innovation and deep human understanding.  For more information, please visit   

About R/GA Ventures

R/GA Ventures works with start-ups and organizations to create a more human future. they do this by identifying disruptive and inspiring technologies and ideas, and supporting those ideas with the financial, creative, and relationship capital neccessary to drive growth and returns. R/GA Ventures has run 31 programmes to date across numerous verticals. R/GA Ventures and R/GA are part of the Interpublic Group of Companies (NYSE:IPG). Learn more at and by following @rgaventures.